Inhaled nitric oxide and arterial oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension

Thorax

Volumn 52, Issue 2, 1997, Pages 120-124

  Katayama, Yoshihiko ^a   Higenbottam, Timothy W ^a   Diaz De Atauri, Maria J ^a   Cremona, George ^a   Akamine, Shinji ^a   Barbera, Joan Albert ^b   Rodriguez Roisin, Robert ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

chronic obstructive pulmonary disease; nitric oxide; pulmonary hypertension

Indexed keywords

BENDROFLUMETHIAZIDE; DIGITOXIN; DILTIAZEM; DOSULEPIN; FRUMIL; FUROSEMIDE; HEPARIN; NITRIC OXIDE; PREDNISOLONE; THYROXINE; WARFARIN;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GAS EXCHANGE; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; NORMAL HUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0031034595     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2.120     Document Type: Article

References (30)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
3. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
4. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-4.
5. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
6. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
7. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47.
8. Adnot S, Kouyoumdjian C, Defouilloy C, Andrivet P, Sediame S, Herigault R, et al. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1993;148:310-6.
9. Moinard J, Manier C, Pillet O, Castaing Y. Effect of inhaled nitric oxide on hemodynamics and Va/Q inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;149:1482-7.
10. Ahluwalia JS, Kelsall AW, Raine J, Rennie JM, Mahmood M, Oduro AL, et al. Safety of inhaled nitric oxide in premature neonates [letter]. Acta Paediatr 1994;83:347-8.
11. Pepke-Zaba J, Higenbottam TW, Dinh Xuan AT, Scott JP, English TAH, Wallwork J. Validation of impedance cardiography measurements of cardiac output during limited exercise in heart transplant recipients. Transplant Int 1990;3:108-12.
12. Cremona GI. Nitric oxide and pulmonary vascular resistance in health and disease. PhD thesis. Cambridge: Cambridge University, 1994: 1-227.
13. Huch A, Huch R, Lubbers DW. Quantitative polarographic measurement of the oxygen pressure on the scalp of the newborn. [German]. Archiv Gynakol 1969;207:443-51.
14. Fenner A, Muller R, Busse HG, Junge M, Wolfsdorf J. Transcutaneous determination of arterial oxygen tension. Pediatrics 1975;23:64-6.
15. Sramek BB. Noninvasive technique for measurement of cardiac output by means of electrical impedance. In: Proceedings of the fifth international conference on electrical bioimpedance, Tokyo. 1981: 39-42.
16. Sramek BB, Rose DM, Miyamoto A. Stroke volume equation with a linear base impedance model and its accuracy, as compared to the thermodilution and magnetic flowmeter techniques in humans and animal. In: Proceedings of the sixth international conference on electrical bioimpedance, Zadar. 1983: 38-41.
17. Cremona G, Takao M, Bower EA, Hall LW, Higenbottam T. The effects of hypoxia, inhaled nitric oxide and endothelial nitric oxide on total and segmental vascular resistance of isolated pig lungs. J Appl Physiol 1996 (in press).
18. Yoshida K, Kasama K, Kitabatake M, Okuda M. Metabolic-fate of nitric oxide. Int Arch Occup Environ Health 1980; 48:71-7.
19. Wennmalm A, Benthin G, Petersson A-S. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992;106:507-8.
20. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993;342: 961-2.
21. Lockhart A, Trareva M, Schrijen F, Sadoul P. Etude des hemodynamiques des decompensations respiratoires aigues des bronchopneumoputhies chroniques. [French]. Bull Physio-Pathol Respir 1967;3:645-67.
22. Agusti AGN, Barbera JA. Contribution of multiple inert gas elimination technique to pulmonary medicine. 2: Chronic pulmonary diseases:chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Thorax 1994;49:924-32.
23. Morrell NW, Wignall BK, Biggs T, Seed A. Collateral ventilation and gas exchange in emphysema. Am J Respir Crit Care 1994;150:635-41.
24. Puybasset L, Rouby JJ, Mourgeon K, Stewart TE, Cluzel P, Belin MF, et al. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994;20: 319-27.
25. Cremona G, Katayama Y, Bower KA, Butt AY, Higenbottam T. Basal and stimulated release of nitric oxide (NO) in isolated human lungs with severe pulmonary hypertension (SPH). Am J Respir Crit Care Med 1995; 151: A626.
26. Warren JB, Maltby NH, MacCormack D, Barnes PJ. Pulmonary endothelium-derived relaxing factor is impaired in hypoxia. Clin Sci 1989;77:671-6.
27. Cremona G, Wood AM, Hall LW, Bower HA, Higenbottam TW. Effects of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol Lond 1994;481.1:185-95.
28. 2 J Clin Invest 1974; 54:54-68.
29. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:A726.
30. Channick RN, Hoch RC, Newhart JW, Johnson FW, Smith CM. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in patients with end-stage pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:811-4.